qimono / Pixabay

Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

Post author:Ellen Johnson
Post published:March 10, 2019
Post category:Rheumatoid Arthritis Rheumatoid nodulosis Rheumatoid vasculitis

Genetic testing, such as 23andMe, has been approved by the FDA for direct-to-consumer genetic testing. However, this type of testing has not been approved to predict rheumatic diseases. Research is…

Get Involved

Ready to get involved with Patient Worthy? Share your authentic story with others. Raise awareness and inspire change!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Get Involved

Can Direct-to-Consumer Genetic Testing Predict Rheumatological Diseases?

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Get Involved

Let’s Work Together!

Keep Up to Date

Learn More